Successful living donor liver retransplantation for graft failure within 7 days due to acute de novo donor-specific anti-human leukocyte antigen antibody-mediated rejection

Yohei Yamada, Ken Hoshino, Teisaburo Mori, Miho Kawaida, Kiyotomo Abe, Hideo Ishihama, Takahiro Shimizu, Nobuhiro Takahashi, Kentaro Matsubara, Taizo Hibi, Yuta Abe, Hiroshi Yagi, Naoki Shimojima, Masahiro Shinoda, Minoru Kitago, Hideaki Obara, Yasushi Fuchimoto, Kaori Kameyama, Yuko Kitagawa, Tatsuo Kuroda

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Growing evidence suggests a relationship between antibody-mediated rejection (AMR) and early graft failure due to a previously unknown etiology in liver transplantation (LTx). We herein report a 3-year-old boy who developed rapid graft failure due to de novo donor-specific antibody (DSA)-driven AMR a week after living donor LTx, requiring a second transplant on the 10th day after the first LTx. The pathology of the first graft showed massive necrosis in zone 3 along with positive C4d and inflammatory cell infiltrates in portal areas. The mean fluorescence intensity against human leukocyte antigen (HLA)-DR15, which was possessed by both the first and the second donor, peaked at 12 945 on the day before the second LTx. Antithymocyte globulin, plasma exchange along with i.v. immunoglobulin, rituximab, and the local infusion of prostaglandin E1, steroids, and Mesilate gabexate through a portal catheter were provided to save the second graft. To our knowledge, this is the first report to show a clear association between de novo DSA and acute AMR within 7 days of a LTx. Furthermore, we successfully rescued the recipient with a second graft despite possessing the same targeted HLA. The rapid decision to carry out retransplantation and specific strategies overcoming AMR were crucial to achieving success in this case of immunologically high-risk LTx.

Original languageEnglish
Pages (from-to)E360-E366
JournalHepatology Research
Volume48
Issue number3
DOIs
Publication statusPublished - 2018 Feb 1

Fingerprint

Living Donors
HLA Antigens
Tissue Donors
Transplants
Antibodies
Liver
Gabexate
Plasma Exchange
Antilymphocyte Serum
Alprostadil
Graft Rejection
Liver Transplantation
Immunoglobulins
Necrosis
Catheters
Fluorescence
Steroids
Pathology

Keywords

  • desensitization
  • donor-specific antibody
  • liver transplantation
  • retransplantation
  • seventh day syndrome

ASJC Scopus subject areas

  • Hepatology
  • Infectious Diseases

Cite this

Successful living donor liver retransplantation for graft failure within 7 days due to acute de novo donor-specific anti-human leukocyte antigen antibody-mediated rejection. / Yamada, Yohei; Hoshino, Ken; Mori, Teisaburo; Kawaida, Miho; Abe, Kiyotomo; Ishihama, Hideo; Shimizu, Takahiro; Takahashi, Nobuhiro; Matsubara, Kentaro; Hibi, Taizo; Abe, Yuta; Yagi, Hiroshi; Shimojima, Naoki; Shinoda, Masahiro; Kitago, Minoru; Obara, Hideaki; Fuchimoto, Yasushi; Kameyama, Kaori; Kitagawa, Yuko; Kuroda, Tatsuo.

In: Hepatology Research, Vol. 48, No. 3, 01.02.2018, p. E360-E366.

Research output: Contribution to journalArticle

@article{14a7f054a40444a6821cb11193682125,
title = "Successful living donor liver retransplantation for graft failure within 7 days due to acute de novo donor-specific anti-human leukocyte antigen antibody-mediated rejection",
abstract = "Growing evidence suggests a relationship between antibody-mediated rejection (AMR) and early graft failure due to a previously unknown etiology in liver transplantation (LTx). We herein report a 3-year-old boy who developed rapid graft failure due to de novo donor-specific antibody (DSA)-driven AMR a week after living donor LTx, requiring a second transplant on the 10th day after the first LTx. The pathology of the first graft showed massive necrosis in zone 3 along with positive C4d and inflammatory cell infiltrates in portal areas. The mean fluorescence intensity against human leukocyte antigen (HLA)-DR15, which was possessed by both the first and the second donor, peaked at 12 945 on the day before the second LTx. Antithymocyte globulin, plasma exchange along with i.v. immunoglobulin, rituximab, and the local infusion of prostaglandin E1, steroids, and Mesilate gabexate through a portal catheter were provided to save the second graft. To our knowledge, this is the first report to show a clear association between de novo DSA and acute AMR within 7 days of a LTx. Furthermore, we successfully rescued the recipient with a second graft despite possessing the same targeted HLA. The rapid decision to carry out retransplantation and specific strategies overcoming AMR were crucial to achieving success in this case of immunologically high-risk LTx.",
keywords = "desensitization, donor-specific antibody, liver transplantation, retransplantation, seventh day syndrome",
author = "Yohei Yamada and Ken Hoshino and Teisaburo Mori and Miho Kawaida and Kiyotomo Abe and Hideo Ishihama and Takahiro Shimizu and Nobuhiro Takahashi and Kentaro Matsubara and Taizo Hibi and Yuta Abe and Hiroshi Yagi and Naoki Shimojima and Masahiro Shinoda and Minoru Kitago and Hideaki Obara and Yasushi Fuchimoto and Kaori Kameyama and Yuko Kitagawa and Tatsuo Kuroda",
year = "2018",
month = "2",
day = "1",
doi = "10.1111/hepr.12924",
language = "English",
volume = "48",
pages = "E360--E366",
journal = "Hepatology Research",
issn = "1386-6346",
publisher = "Wiley-Blackwell Publishing Ltd",
number = "3",

}

TY - JOUR

T1 - Successful living donor liver retransplantation for graft failure within 7 days due to acute de novo donor-specific anti-human leukocyte antigen antibody-mediated rejection

AU - Yamada, Yohei

AU - Hoshino, Ken

AU - Mori, Teisaburo

AU - Kawaida, Miho

AU - Abe, Kiyotomo

AU - Ishihama, Hideo

AU - Shimizu, Takahiro

AU - Takahashi, Nobuhiro

AU - Matsubara, Kentaro

AU - Hibi, Taizo

AU - Abe, Yuta

AU - Yagi, Hiroshi

AU - Shimojima, Naoki

AU - Shinoda, Masahiro

AU - Kitago, Minoru

AU - Obara, Hideaki

AU - Fuchimoto, Yasushi

AU - Kameyama, Kaori

AU - Kitagawa, Yuko

AU - Kuroda, Tatsuo

PY - 2018/2/1

Y1 - 2018/2/1

N2 - Growing evidence suggests a relationship between antibody-mediated rejection (AMR) and early graft failure due to a previously unknown etiology in liver transplantation (LTx). We herein report a 3-year-old boy who developed rapid graft failure due to de novo donor-specific antibody (DSA)-driven AMR a week after living donor LTx, requiring a second transplant on the 10th day after the first LTx. The pathology of the first graft showed massive necrosis in zone 3 along with positive C4d and inflammatory cell infiltrates in portal areas. The mean fluorescence intensity against human leukocyte antigen (HLA)-DR15, which was possessed by both the first and the second donor, peaked at 12 945 on the day before the second LTx. Antithymocyte globulin, plasma exchange along with i.v. immunoglobulin, rituximab, and the local infusion of prostaglandin E1, steroids, and Mesilate gabexate through a portal catheter were provided to save the second graft. To our knowledge, this is the first report to show a clear association between de novo DSA and acute AMR within 7 days of a LTx. Furthermore, we successfully rescued the recipient with a second graft despite possessing the same targeted HLA. The rapid decision to carry out retransplantation and specific strategies overcoming AMR were crucial to achieving success in this case of immunologically high-risk LTx.

AB - Growing evidence suggests a relationship between antibody-mediated rejection (AMR) and early graft failure due to a previously unknown etiology in liver transplantation (LTx). We herein report a 3-year-old boy who developed rapid graft failure due to de novo donor-specific antibody (DSA)-driven AMR a week after living donor LTx, requiring a second transplant on the 10th day after the first LTx. The pathology of the first graft showed massive necrosis in zone 3 along with positive C4d and inflammatory cell infiltrates in portal areas. The mean fluorescence intensity against human leukocyte antigen (HLA)-DR15, which was possessed by both the first and the second donor, peaked at 12 945 on the day before the second LTx. Antithymocyte globulin, plasma exchange along with i.v. immunoglobulin, rituximab, and the local infusion of prostaglandin E1, steroids, and Mesilate gabexate through a portal catheter were provided to save the second graft. To our knowledge, this is the first report to show a clear association between de novo DSA and acute AMR within 7 days of a LTx. Furthermore, we successfully rescued the recipient with a second graft despite possessing the same targeted HLA. The rapid decision to carry out retransplantation and specific strategies overcoming AMR were crucial to achieving success in this case of immunologically high-risk LTx.

KW - desensitization

KW - donor-specific antibody

KW - liver transplantation

KW - retransplantation

KW - seventh day syndrome

UR - http://www.scopus.com/inward/record.url?scp=85041827491&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85041827491&partnerID=8YFLogxK

U2 - 10.1111/hepr.12924

DO - 10.1111/hepr.12924

M3 - Article

VL - 48

SP - E360-E366

JO - Hepatology Research

JF - Hepatology Research

SN - 1386-6346

IS - 3

ER -